✦ LIBER ✦

P-562 Phase I clinical trial with Topotecan, Adriamycin and Vincristine (TAV) in patients with advanced Small (SCLC) and Non-Small Cell Lung Cancer (NSCLC

✍ Scribed by Padmanabhan, Swaminathan; Raez, Luis E.; Santos, Edgardo; Tang, Shou-ching; Ramos, Juan C.; Rosado, Francisco; Baldie, Paulette; Farfan, Nancy; Sridhar, Kasi

Book ID: 118572257
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 188 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92529-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II studies of topotecan in patient

Phase II studies of topotecan in patients with non-small cell lung cancer (NSCLC) previously untreated and patients with small cell lung (SCLC) cancer refractory to etoposide

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 132 KB

A phase I trial of gefitinib and nimotuz

A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)

✍ Kim, Se Hyun; Shim, Hyo Sup; Cho, Jaeho; Jeong, Jae Heon; Kim, Sun Mi; Hong, Yun 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 275 KB

169 Phase III trial of paclitaxel (P) an

169 Phase III trial of paclitaxel (P) and oral etoposide (E) in patients with small cell (SCLC) or non-small cell (NSCLC) lung cancer

✍ Boyer, M.J.; Zalcberg, J.; Olver, L.N.; Millward, M.J.; Richardson, G.; McKeage, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Phase II trial of MTA (AlimtaTM) and cis

Phase II trial of MTA (AlimtaTM) and cisplatin in patients with advanced Non-Small Cell Lung Cancer (NSCLC)

✍ Shepherd, F.A; Arnold, A; Neville, A; Dancey, J; Rusthoven, J; Fisher, B; Eisenh 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

A phase I trial of the combination taxot

A phase I trial of the combination taxotere® (docetaxel) and cisplatin in patients with advanced non-small cell lung cancer (NSCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Preliminary report on gemcitabine (G) —

Preliminary report on gemcitabine (G) — Ifosfamide (I) — Cisplatin (P) phase I/II trial in patients with advanced non small cell lung cancer (NSCLC)

✍ Bourgeois, H.; Lemerre, D.; Chicoyneau, V.; Paitry, T.; Chieze, S.; Fruge, F.; B 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB